510(k) K770453

PHOSPHATASE PROCEDURE, TEKPOINT ALKALINE by Icn Pharmaceuticals, Inc. — Product Code CIO

K770453 is an FDA 510(k) premarket notification submitted by Icn Pharmaceuticals, Inc. for the device "PHOSPHATASE PROCEDURE, TEKPOINT ALKALINE". The FDA issued a decision of Substantially Equivalent on May 3, 1977. The device falls under product code CIO (Thymolphthalein Monophosphate, Alkaline Phosphatase Or Isoenzymes), a Class II device regulated under 21 CFR 862.1050. Icn Pharmaceuticals, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
May 3, 1977
Date Received
March 8, 1977
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Thymolphthalein Monophosphate, Alkaline Phosphatase Or Isoenzymes
Device Class
Class II
Regulation Number
862.1050
Review Panel
CH
Submission Type